Mechanisms and Management of Inflammation-driven Cardiovascular Risk: from Obesity and Diabetes to Autoimmunity and Cancer

  • 1,836

    Total downloads

  • 7,838

    Total views and downloads

Articles

CLINICAL TRIAL

Published on 21 Feb 2024

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

  • Lucas Lage Marinho
  • Fabiana Hanna Rached
  • Aleksandra Tiemi Morikawa
  • Thauany Martins Tavoni
  • Ana Paula Toniello Cardoso
  • Roberto Vitor Almeida Torres
  • Antonildes Nascimento Assuncao
  • Carlos Vicente Serrano
  • Cesar Higa Nomura
  • Raul Cavalcante Maranhão
Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study
doi 10.3389/fcvm.2024.1342832
  • 1,572 views